These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20629151)

  • 41. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.
    Prakash BD; Sitoh YY; Tan LC; Au WL
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1029-33. PubMed ID: 22705126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.
    Walter U
    Expert Rev Neurother; 2009 Jun; 9(6):835-46. PubMed ID: 19496687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.
    Liepelt-Scarfone I; Gauss K; Maetzler W; Müller K; Bormann C; Fruhmann Berger M; Timmers M; Streffer J; Berg D
    Neuroepidemiology; 2013; 41(3-4):174-82. PubMed ID: 24051361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcranial brain parenchyma sonography in movement disorders: state of the art.
    Walter U; Behnke S; Eyding J; Niehaus L; Postert T; Seidel G; Berg D
    Ultrasound Med Biol; 2007 Jan; 33(1):15-25. PubMed ID: 17189043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined assessment by transcranial sonography and Sniffin' Sticks test has a similar diagnostic accuracy compared to brain SPECT for Parkinson's disease diagnosis.
    Almeida KJ; Bor-Seng-Shu E; Pedroso JL; Felicio AC; de-Lima-Oliveira M; Barsottini OGP; de Carvalho Nogueira R; Paschoal-Júnior FM; Borges V; Batista IR; Teixeira MJ; Ferraz HB; Walter U
    Clin Neurol Neurosurg; 2022 Sep; 220():107333. PubMed ID: 35816824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
    Walter U; Wittstock M; Benecke R; Dressler D
    J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasound.
    Subramanian T; Lieu CA; Guttalu K; Berg D
    Ultrasound Med Biol; 2010 Apr; 36(4):604-9. PubMed ID: 20211515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substantia nigra hyperechogenicity in hypokinetic Huntington's disease patients.
    Lambeck J; Niesen WD; Reinhard M; Weiller C; Dose M; Zucker B
    J Neurol; 2015 Mar; 262(3):711-7. PubMed ID: 25572159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcranial sonography in essential tremor.
    Stockner H; Wurster I
    Int Rev Neurobiol; 2010; 90():189-97. PubMed ID: 20692503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity.
    Schweitzer KJ; Behnke S; Liepelt I; Wolf B; Grosser C; Godau J; Gaenslen A; Bruessel T; Wendt A; Abel F; Müller A; Gasser T; Berg D
    J Neural Transm (Vienna); 2007 Sep; 114(9):1167-71. PubMed ID: 17446999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease.
    Millar Vernetti P; Perez Lloret S; Rossi M; Cerquetti D; Merello M
    Parkinsonism Relat Disord; 2012 May; 18(4):358-61. PubMed ID: 22227345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substantia nigra echogenicity in progressive supranuclear palsy.
    Ebentheuer J; Canelo M; Trautmann E; Trenkwalder C
    Mov Disord; 2010 Apr; 25(6):773-7. PubMed ID: 20198715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcranial sonography in the premotor diagnosis of Parkinson's disease.
    Behnke S; Schröder U; Berg D
    Int Rev Neurobiol; 2010; 90():93-106. PubMed ID: 20692496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcranial ultrasound as a risk marker for Parkinson's disease.
    Berg D
    Mov Disord; 2009; 24 Suppl 2():S677-83. PubMed ID: 19877199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between substantia nigra features detected by sonography and Parkinson disease symptoms.
    Bártová P; Skoloudík D; Ressner P; Langová K; Herzig R; Kanovsky P
    J Ultrasound Med; 2010 Jan; 29(1):37-42. PubMed ID: 20040773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Transcranial sonography (TCS) in evaluation of patients with essential tremor].
    Budisić M; Trkanjec Z; Lovrencić-Huzjan A; Supanc V; Vuković V; Demarin V
    Acta Med Croatica; 2009 Dec; 63 Suppl 3():51-4. PubMed ID: 20232670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease.
    Iova A; Garmashov A; Androuchtchenko N; Kehrer M; Berg D; Becker G; Garmashov Y
    J Neurol; 2004 Dec; 251(12):1451-4. PubMed ID: 15645343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson's Disease Rating Scale in the elderly population.
    Liepelt-Scarfone I; Lerche S; Behnke S; Godau J; Gaenslen A; Pausch C; Fassbender K; Brockmann K; Srulijes K; Huber H; Wurster I; Berg D
    J Neurol; 2015 Feb; 262(2):451-8. PubMed ID: 25451854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Identification of people at the latent stage of Parkinson's disease (the PARKINLAR study): first results and an optimization of the algorithm].
    Fedotova EY; Chechetkin AO; Abramycheva NY; Chigaleychik LA; Baziyan BK; Ponomareva ТА; Alexeeva NS; Fedin PA; Kravchenko MA; Varakin YY; Ivanova-Smolenskaya IA; Illarioshkin SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):4-11. PubMed ID: 26356391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sonographic abnormality of the substantia nigra in melanoma patients.
    Rumpf JJ; Weise D; Fricke C; Wetzig T; Simon JC; Classen J
    Mov Disord; 2013 Feb; 28(2):219-23. PubMed ID: 23114984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.